Title
Multinucleate giant cells release functionally unopposed matrix metalloproteinase-9 in vitro and in vivo
Date Issued
22 October 2007
Access level
open access
Resource Type
journal article
Author(s)
Xing W.Z.
Price N.M.
Recarvarren S.
Friedland J.S.
Abstract
Multinucleated giant cells (MGCs) are characteristic of granulomatous inflammation. Matrix metalloproteinase (MMP)-9, the major monocyte-derived matrix metalloproteinase, is key in inflammatory tissue damage. At 72 h, MGCs secrete 153 ± 2.5 ng/mL MMP-9, compared with 115 ± 3.8 ng/mL during macrophage differentiation (P < .05). In contrast, the level of MGC secretion-specific tissue inhibitor, tissue inhibitor of metalloproteinase (TIMP)-1, is lower (P < .05). Mature MGCs secrete constitutively greater concentrations of MMP-9 than do monocytes or macrophages (P < .05). MGCs in tuberculous lymph-node biopsy samples express high MMP-9 levels adjacent to areas of necrosis, whereas TIMP-1 is not detected. Thus, MGCs are potentially important sources of MMP-9 secretion and may contribute to inflammatory tissue damage in human tuberculosis. © 2007 by the Infectious Diseases Society of America. All rights reserved.
Start page
1076
End page
1079
Volume
196
Issue
7
Language
English
OCDE Knowledge area
Enfermedades infecciosas Biología celular, Microbiología
Scopus EID
2-s2.0-35348918774
PubMed ID
Source
Journal of Infectious Diseases
ISSN of the container
00221899
Sponsor(s)
Received 22 January 2007; accepted 16 April 2007; electronically published 20 August 2007. Potential conflicts of interest: none reported. Financial support: Dunhill Medical Trust (grant to J.S.F.). Reprints or correspondence: Prof. Jon S. Friedland, Dept. of Infectious Diseases and Immunity, Imperial College London, Hammersmith Hospital, Du Cane Rd., London, W12 0NN, England (j.friedland@imperial.ac.uk).
Sources of information: Directorio de Producción Científica Scopus